Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis

Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis

Detaylı Bibliyografya
Asıl Yazarlar:	Robinson, DE, Tan, EH, Jödicke, A, Mosseveld, M, Bødkergaard, K, Reyes, C, Voss, A, Marconi, E, Lapi, F, Reinold, J, Verhamme, K, Pedersen, L, De Wilde, M, Far, M, Aragón, M, Bosco-Levy, P, Lassalle, R, Prieto Alhambra, D
Materyal Türü:	Conference item
Dil:	English
Baskı/Yayın Bilgisi:	Springer 2022

Benzer Materyaller

The impact of COVID-19 on population-level drug utilization of alendronate
Yazar:: Tan, EH, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Patient characteristics of new initiators of glycopyrronium bromide (GLY) – A multinational, multi-database real-world drug-utilization study
Yazar:: Verhamme, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Multinational cohort study of mortality in patients with asthma and severe asthma
Yazar:: Engelkes, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma
Yazar:: Verhamme, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data
Yazar:: Platzbecker K, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study
Yazar:: Baan, E, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis
Yazar:: Kostka, K, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance
Yazar:: Berencsi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom
Yazar:: Jödicke, AM, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Fracture risk following the initiation of antihypertensive therapy amongst frail elderly people: a self-controlled case series analysis
Yazar:: Jödicke, AM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Risk of falls following the initiation of antihypertensives in the elderly: a self-controlled case series in the UK
Yazar:: Jödicke, AM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
Yazar:: Martin-Merino, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The burden of long COVID: a multinational cohort analysis of Spanish and UK data including SARS-CoV-2 infections, reinfections, and matched contemporaneous test negative controls
Yazar:: Prieto Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis
Yazar:: Kristin Kostka, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance
Yazar:: Ying, H, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Prevalence of reduced renal function in the osteoporosis clinic and implications for the osteoporosis treatment gap - a study of 26,000 DXA referrals in a singleprovider geographical area
Yazar:: Abrahamsen, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Validation of COPD ICD10 diagnostic codes in the SIDIAP Primary Health Care research database using a combination of spirometry measures, symptoms, drug use, and free text review
Yazar:: Reyes, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

[Degenerative osteoarthritis, osteoporosis and fractures: controversies and evidences].
Yazar:: Pagès-Castellà, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Artrosis, osteoporosis y fracturas: controversias y evidencias
Yazar:: Pagès-Castellà, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Deep learning to detect features of a population of anti-osteoporosis drug users
Yazar:: Khalid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Deep learning for drug utilisation research: Identifying features within a population of anti-osteoporosis drug users
Yazar:: Khalid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Machine learning for risk factor identification and cardiovascular mortality prediction among patients with osteoporosis
Yazar:: Hasheminasab, AH, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
Yazar:: Li, X, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis
Yazar:: Guo, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis
Yazar:: Yuchen Guo, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
Yazar:: Hawley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis
Yazar:: Khalid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Data-driven cluster analysis for identifying groups within users of anti-osteoporosis medication, using real-world primary care data.
Yazar:: Khalid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
Yazar:: Oda, T, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Osteoarthritis Is Related to An Increased Risk of Falls and Fractures: A Prospective Multinational Cohort Study (the GLOW study)
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Taxing multinationals
Yazar:: Devereux, M, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The impact of risk minimisation measures on the incidence and prevalence of use of strontium ranelate at the population level: preliminary results of a multi-national cohort study including 5 European countries
Yazar:: Berencsi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study
Yazar:: Pauline Bosco‐Lévy, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Techniques for characterising long COVID in real world data
Yazar:: Kostka, K, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study
Yazar:: Prats Uribe, A, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Yazar:: Lane, JCE, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Multinationals and transfer pricing /
Yazar:: Eden, Lorraine, ve diğerleri
Baskı/Yayın Bilgisi: (1985)

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study
Yazar:: Aniek F. Markus, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Multinational business finance /
Yazar:: 320281 Eiteman, David K., ve diğerleri
Baskı/Yayın Bilgisi: (1979)

Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
Yazar:: Català, M, ve diğerleri
Baskı/Yayın Bilgisi: (2023)